Irrfan Khan On His Film Doob: No Bed Of Roses Selected As Bangladesh's Oscar Entry: It's An Honour
Irrfan Khan who is currently undergoing treatment for neuroendocrine tumour in London, is quite elated that the Bangladesh Oscar Committee has chosen his film, Doob to represent the country at Oscars.
Doob:
No
Bed
of
Roses,
Bangladesh's
Oscar
entry
in
the
best
foreign
language
film
category,
would
not
have
been
possible
without
Indian
actor
Irrfan
Khan,
says
the
movie's
director
Mostofa
Sarwar
Farooki.
The
2017
bilingual
drama
stars
Irrfan,
who
has
also
co-produced
it.
Meanwhile
the
actor,
who
is
currently
undergoing
treatment
for
neuroendocrine
tumour
in
London,
is
quite
elated
that
the
Bangladesh
Oscar
Committee
has
chosen
Doob
to
represent
the
country
at
the
Academy
Awards.
The
actor's
spokesperson
said
in
a
statement
on
Irrfan's
behalf:
"It
is
an
honour
to
be
recognised
by
the
jury
and
he
is
delighted
that
his
film
is
getting
the
much
deserved
acknowledgement
at
long
last."Farooki
said:
"I
am
happy
because
'No
Bed
of
Roses'
is
representing
Bangladesh
at
the
Oscars.
I
hope
the
film
would
find
some
love
from
the
Academy
voters.
As
for
my
collaboration
with
Irrfan,
it
would
have
been
impossible
to
make
this
film
without
his
involvement
as
an
actor
and
co-producer.
"I
share
a
wonderful
relation
with
him,
on
and
off
the
set.
I
call
him
'poet' and
he
jokingly
corrects
me
saying
'I'm
a
poet
with
no
words'.
In
this
film,
he
actually
expressed
so
many
things
with
very
little
help
of
words
and
I
am
glad
to
have
collaborated
with
one
of
the
finest
actors
of
not
just
India,
but
the
world."
Doob
has
Irrfan
essaying
the
role
of
a
successful
filmmaker
facing
a
midlife
crisis
when
he
has
a
tryst
with
his
daughter's
childhood
friend,
causing
a
national
scandal.
The
film
was
initially
banned
in
Bangladesh
on
the
grounds
that
it
might
be
based
on
revered
real-life
author
and
filmmaker
Ahmed,
who
divorced
his
wife
of
27
years
and
married
an
actress
33
years
his
junior.
Later,
the
ban
was
eventually
lifted
and
the
film
released
in
October
2017
in
Bangladesh,
France,
India
and
Australia.